@pancryos.com
PanCryos develops a next generation stem cell derived allogenic cell therapy or Type 1 diabetes.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Pancryos is a leading brand dedicated to improving the quality of life for millions of people suffering from diabetes. Specializing in next generation stem cell derived cell therapy, Pancryos is at the forefront of revolutionizing the treatment of diabetes with their innovative product, PanINSULA™. Unlike traditional insulin therapy, CGMs, and insulin pumps that attempt to mimic the function of the beta cell and require constant patient intervention, Pancryos aims to provide a natural solution.
Their beta cell therapy seeks to effectively control and cure diabetes by sensing changes in blood glucose levels and producing insulin without any outside intervention. Pancryos is a spin-off from the University of Copenhagen, building upon groundbreaking research conducted at the renowned Novo Nordisk Foundation Center for Stem Cell Biology (DanStem). With their dedication to improving the lives of those with diabetes, Pancryos is making significant strides towards a brighter future.
Copyright PANCRYOS © 2017. All rights reserved
Company Type
Privately Held
Company Size
2-10
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online